High flow nasal oxygen (HFNO) delivers precise, warmed, and humidified oxygen at flows up to 60 L/min through a wide bore nasal cannula. For clinicians in acute care, perioperative, and emergency settings, safe use of highflow nasal oxygen hfno with special reference to patient selection and protocolized care is essential to maximize benefit and minimize complications.
This article outlines practical steps, monitoring parameters, and clinical considerations to integrate HFNO safely into daily practice. The structured summary below highlights key variables that guide safe initiation, adjustment, and discontinuation.
| Parameter | Recommended Practice | Target / Threshold | Source / Guideline Reference |
|---|---|---|---|
| Flow Range | Start at prescription, titrate to clinical and physiologic targets | Typically 20–60 L/min as needed | Society of Critical Care Medicine guidance |
| FiO2 Monitoring | Confirm delivered oxygen using analyzer or integrated sensor | Maintain SpO2 94–98% or target for condition | Respiratory therapy protocol |
| Patient Selection | Assess airway, respiratory effort, hemodynamics, and facial integrity | Stable upper airway, adequate spontaneous ventilation | Institutional HFNO pathway |
| Humidification & Temperature | Use built-in humidifier with sterile water; monitor circuit temperature | Avoid circuit condensation and skin injury | Equipment safety checklist |
Patient Selection And Clinical Indications
Appropriate Use Cases
Identify patients who are likely to benefit from HFNO, such as those with acute hypoxemic respiratory failure, weaning from high oxygen requirements, or postoperative oxygen support. Exclude cases with obstructed airways, inability to protect the airway, or severe facial trauma where seal cannot be achieved.
Comorbidities And Precautions
Review underlying conditions like coagulopathy, recent facial surgery, or severe obstructive sleep apnea that may increase risk. Coordinate with anesthesia or critical care when comorbidities complicate routine management.
Setup And Circuit Safety
Equipment Inspection And Priming
Before each use, verify that the HFNO device, tubing, and nasal cannula are intact and within service life. Use only sterile, mineral oil–based nasal gel as recommended to prevent mucosal irritation and ensure comfort during prolonged therapy.
Flow Calibration And FiO2 Verification
Set initial flow and FiO2 according to protocol, then confirm delivered oxygen with a calibrated analyzer. Record settings at the bedside and check for air leaks around the cannula to ensure accurate delivery.
Monitoring Parameters And Titration
Physiologic And Clinical Indicators
Continuously monitor respiratory rate, SpO2, heart rate, blood pressure, and work of breathing. Use waveform capnography or end tidal CO2 when available to detect ventilation changes early.
Adjusting Flow And Recognizing Failure
Increase flow incrementally to maintain target oxygenation while minimizing airway pressure. If persistent desaturation, worsening work of breathing, or new arrhythmias occur, escalate to noninvasive ventilation or invasive mechanical ventilation as indicated.
Complications And Contraindications
Identifying And Managing Adverse Events
Be alert to nasal bridge pressure injury, epistaxis, skin breakdown, and patient discomfort. Remove the device early if severe dryness, bleeding, or claustrophobia develops, and consider alternative oxygen delivery or airway support strategies.
When HFNO Should Be Avoided
Avoid HFNO in patients with unprotected airways, severe facial burns or trauma, inability to clear secretions, or uncooperative agitation that compromises circuit integrity. In these scenarios, choose invasive or alternative respiratory support promptly.
Implementation And Best Practices
Establish clear protocols, staff education, and equipment checks to ensure reliable, safe delivery of HFNO across care areas.
- Use a standardized checklist for patient selection, setup, and verification
- Train clinicians on device operation, humidification, and complication recognition
- Integrate HFNO into rapid response and perioperative pathways with clear criteria for escalation
- Document settings, monitoring data, and clinical response for quality improvement and audit
FAQ
Reader questions
How do I determine if a patient is a good candidate for HFNO with special reference to safety?
Assess for intact upper airway, adequate spontaneous ventilation, and stable hemodynamics; review contraindications such as facial trauma or coagulopathy; and ensure close monitoring protocols are in place before initiation.
What initial settings should I use when starting HFNO for safe oxygenation?
Begin at prescription flow and FiO2, titrate to SpO2 target of 94–98%, verify delivered oxygen with an analyzer, and document baseline respiratory rate and work of breathing to guide upward adjustments.
What parameters should I monitor continuously during HFNO therapy?
Monitor SpO2, respiratory rate, heart rate, blood pressure, end tidal CO2 when available, circuit air leak, and patient comfort; reassess at least hourly or sooner if clinical status changes.
What are the signs that HFNO is failing and escalation is needed?
Escalate care if persistent desaturation, rising respiratory rate, increased accessory muscle use, new arrhythmias, or signs of air trapping develop; coordinate with intensivist or anesthesia for noninvasive or invasive ventilation.